Orlistato Ratiopharm

Orlistat, the active ingredient in Orlistato Ratiopharm, is a Lip Lip presented as a 120mg tablet for oral use. It inhibits intestinal fat absorption and is used in the management of obesity in adults. GNH USA supplies Orlistato Ratiopharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Orlistato Ratiopharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Orlistat is indicated for the treatment of obesity and related metabolic conditions.

- Obesity: Reduces body weight when combined with a reduced‑calorie diet. - Overweight with risk factors: Assists in weight loss for patients with a BMI ≥ 27 kg/m² who have comorbidities such as hypertension or dyslipidaemia. - Weight‑maintenance: Helps maintain weight loss achieved through diet and lifestyle changes. - Post‑bariatric surgery: Supports continued weight management after surgical weight‑loss procedures. - Metabolic syndrome: Contributes to improvement of lipid profiles when used as part of a comprehensive management plan.

Adverse reactions to Orlistat are primarily related to its mechanism of reducing fat absorption.

Common Side Effects: - Oily spotting: Appearance of oily droplets on underwear or clothing. - Fecal urgency: Increased frequency of bowel movements. - Flatulence with discharge: Gas accompanied by oily discharge. - Abdominal cramping: Discomfort or pain in the abdominal region. - Loose stools: Frequent, watery stools. - Reduced absorption of fat‑soluble vitamins: Lowered levels of vitamins A, D, E and K.

Serious or Rare Side Effects: - Liver injury: Signs of hepatitis or abnormal liver function tests. - Severe allergic reaction: Rash, itching, swelling, dizziness or trouble breathing. - Pancreatitis: Sudden, severe abdominal pain radiating to the back. - Kidney stones: Flank pain, hematuria or urinary obstruction. - Persistent diarrhea: Ongoing watery stools leading to dehydration. - Acute colitis: Inflammation of the colon presenting with blood in stool.

When using Orlistat, certain precautions should be observed to ensure safety and effectiveness.

- Assess BMI: Confirm that the patient meets the BMI criteria for treatment. - Monitor vitamin levels: Supplement fat‑soluble vitamins regularly to prevent deficiencies. - Review medical history: Check for history of malabsorption, cholestasis or pancreatitis. - Counsel on diet: Advise a low‑fat diet to minimise gastrointestinal side effects. - Evaluate liver function: Periodic liver enzyme testing is recommended. - Store at ambient temperature: Keep below 25°C in the original packaging, protected from moisture.

Orlistat can interact with several medicines and nutrients, affecting their absorption or efficacy.

Major Interactions (Avoid): - Cyclosporine: Reduced absorption may lower immunosuppressive effect. - Levothyroxine: Decreased uptake can compromise thyroid hormone replacement. - Warfarin: Altered vitamin K absorption may affect anticoagulation control.

Moderate Interactions (Monitor Closely): - Fat‑soluble vitamins (A, D, E, K): Co‑administration requires supplementation. - Beta‑blockers: Possible reduction in drug plasma levels. - Antiretrovirals (e.g., ritonavir): May experience reduced efficacy due to decreased fat absorption.